org placeholder image

Martin Jacko

Chief Executive Officer at Aperture Therapeutics

  • LinkedIn

Email Email: m****@aperturetx.com

phone noPhone Number: (***)-***-****

As the CEO of Aperture Therapeutics, I lead a biotech company that develops innovative therapies for age-related neurodegenerative diseases using RNA-based technologies and immunomodulati...

Read More

map
APERTURE THERAPEUTICS

APERTURE THERAPEUTICS

  • description Description
    Aperture Therapeutics is a pre-clinical stage drug discovery company focusing on age-related neurodegenerative disorders. The company is developing an innovative drug discovery platform based...

    Read More

  • Employees count Employees 1-10
  • Revenue Revenue 25 Million to 50 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Aperture Therapeutics Org Chart and Mapping

Martin Jacko

Chief Executive Officer

Frequently Asked Questions Regarding Martin Jacko

Answer: Martin Jacko works for Aperture Therapeutics as Chief Executive Officer

Answer: Martin Jacko’s role in Aperture Therapeutics is Chief Executive Officer

Answer: Martin Jacko's email address is m***@gmail.com

Answer: Martin Jacko's business email address is m****@aperturetx.com

Answer: Martin Jacko’s direct phone number is (***)-***-****

Answer: Martin Jacko works in the industry of: Biotechnology

Answer: Martin Jacko is the current Chief Executive Officer at Aperture Therapeutics.... Read More

Answer: Martin Jacko works Aperture Therapeutics located at 733 Industrial Rd, San Carlos, California, 94070, United States

Answer: Aperture Therapeutics's Chief Executive Officer is Martin Jacko

Answer: Martin Jacko contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@aperturetx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access